• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Frank Taylor, USA

      Frank Taylor, USA

    • Purningam Jacob, India

      Purningam Jacob, India

    • Richard Clark, New Zealand

      Richard Clark, New Zealand

    • Malu Araujo Ribeiro, Brazil

      Malu Araujo Ribeiro, Brazil

    • Gudjon Sigurdsson, Iceland

      Gudjon Sigurdsson, Iceland

    • Torben Mikkelsen, Denmark

      Torben Mikkelsen, Denmark

    • Jorge Melo, Brazil

      Jorge Melo, Brazil

    • David Hall, USA

      David Hall, USA

    • Bob Simonds, USA

      Bob Simonds, USA

    • Bayley, Australia

      Bayley, Australia

    • Shay Rishoni, Netherlands

      Shay Rishoni, Netherlands

    • Andrew Langat, Kenya

      Andrew Langat, Kenya

    • Colm Francis Davis, Ireland

      Colm Francis Davis, Ireland

    • Willi Klein, UK

      Willi Klein, UK

    • Marcelo Farinelli, Brazil

      Marcelo Farinelli, Brazil

    • Amparo Muriel Engativa, Colombia

      Amparo Muriel Engativa, Colombia

    • Elkin Ramiro Gaviria Muñoz, Colombia

      Elkin Ramiro Gaviria Muñoz, Colombia

    • Duncan Bayly, Australia

      Duncan Bayly, Australia

    • John Russo, USA

      John Russo, USA
      final3878

    • David Solomon, UK

      David Solomon, UK

    • PALS and CALS, Singapore

      PALS and CALS, Singapore

    • David Bishop, UK

      David Bishop, UK

    • Joyce Rusinak, USA

      Joyce Rusinak, USA

    • Jeff Sutherland, Canada

      Jeff Sutherland, Canada
      jspic

    • Claudette Sturk, Canada

      Claudette Sturk, Canada
      Picture2

    • Verónica Isabel Castro Molina, Argentina

      Verónica Isabel Castro Molina, Argentina

    • Liam Dwyer, England

      Liam Dwyer, England

    • Jay Epstein, USA

      Jay Epstein, USA

    • Soledad Rodriguez, Spain

      Soledad Rodriguez, Spain

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Rudiger Hanemann, Germany

      Rudiger Hanemann, Germany

    • Erwin Coppejans, Belgium

      Erwin Coppejans, Belgium

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Mauril Bélanger, Canada

      Mauril Bélanger, Canada

    • Daniela Maria Daverio, Argentina

      Daniela Maria Daverio, Argentina

    • Wiebke Braach, Germany

      Wiebke Braach, Germany

    • Elisabeth Zahnd, Switzerland

      Elisabeth Zahnd, Switzerland

    • Marcel R. Wernard, Netherlands

      Marcel R. Wernard, Netherlands

    • Mike Rannie, Canada

      Mike Rannie, Canada

    • Ali Var, Turkey

      Ali Var, Turkey

    • Maurice LeClerc, Canada

      Maurice LeClerc, Canada

    • Carlos Gomez Matallanas, Spain

      Carlos Gomez Matallanas, Spain

    • Roy Taylor, Ireland

      Roy Taylor, Ireland
      roy

    • Leon Ryba, Argentina

      Leon Ryba, Argentina

    • Diana Fernandez, Argentina

      Diana Fernandez, Argentina

    • Kris Van Reusel, Belgium

      Kris Van Reusel, Belgium

    • John Dinon, Australia

      John Dinon, Australia

    • Joy Blakeley, Australia

      Joy Blakeley, Australia

    • Ismail Gokcek, Turkey

      Ismail Gokcek, Turkey
      ismail_gokcek_alsmnd_tr

    • Daniel Hare, USA

      Daniel Hare, USA

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login